Back to User profile » Dr Nicola Gianotti
Papers published by Dr Nicola Gianotti:
Outcome of Darunavir–Cobicistat-Based Regimens in HIV-Infected People Who Have Experienced Virological Failure
Alberton F, Galli L, Lolatto R, Candela C, Gianotti N, Chiurlo M, Ranzenigo M, Strano M, Uglietti A, Castagna A
Drug Design, Development and Therapy 2024, 18:1153-1163
Published Date: 10 April 2024
![Plain language summary](assets/img/article_icons/plain-language.png)
Bictegravir/Emtricitabine/Tenofovir Alafenamide Treatment: Efficacy and Tolerability in Clinical Practice
Canetti D, Galli L, Lolatto R, Nozza S, Spagnuolo V, Muccini C, Trentacapilli B, Bruzzesi E, Ranzenigo M, Chiurlo M, Castagna A, Gianotti N
Drug Design, Development and Therapy 2023, 17:3697-3706
Published Date: 8 December 2023
![Highly-accessed](assets/img/article_icons/highly-accessed.png)
Switching from a Non-Protease Inhibitor-Based Regimen to the Fixed Dose Combination of Darunavir/Cobicistat/Emtricitabine/Tenofovir Alafenamide in Clinical Practice [Corrigendum]
Ranzenigo M, Gianotti N, Galli L, Poli A, Mastrangelo A, Bruzzesi E, Chiurlo M, Nozza S, Bossolasco S, Spagnuolo V, Mancusi D, Termini R, Carini E, Lazzarin A, Castagna A
Drug Design, Development and Therapy 2022, 16:3737-3738
Published Date: 27 October 2022
![Highly-accessed](assets/img/article_icons/highly-accessed.png)
Switching from a Non-Protease inhibitor-Based Regimen To the Fixed Dose Combination of Darunavir/Cobicistat/Emtricitabine/Tenofovir Alafenamide in Clinical Practice
Ranzenigo M, Gianotti N, Galli L, Poli A, Mastrangelo A, Bruzzesi E, Chiurlo M, Nozza S, Bossolasco S, Spagnuolo V, Mancusi D, Termini R, Carini E, Lazzarin A, Castagna A
Drug Design, Development and Therapy 2022, 16:1975-1982
Published Date: 27 June 2022
![Highly-accessed](assets/img/article_icons/highly-accessed.png)
Cardiovascular adverse events during treatment with darunavir-based regimens in an Italian observational study
Antinori A, Rusconi S, Gianotti N, Bini T, Mancusi D, Termini R
Drug Design, Development and Therapy 2019, 13:1667-1685
Published Date: 14 May 2019
![Highly-accessed](assets/img/article_icons/highly-accessed.png)
Effectiveness, durability, and safety of darunavir/ritonavir in HIV-1-infected patients in routine clinical practice in Italy: a postauthorization noninterventional study
Antinori A, Meraviglia P, d’Arminio Monforte A, Castagna A, Mussini C, Bini T, Gianotti N, Rusconi S, Colella E, Airoldi G, Mancusi D, Termini R
Drug Design, Development and Therapy 2016, 10:1589-1603
Published Date: 6 May 2016